Comvita

Comvita, a Pharmaceutical Preparation Manufacturing company based in New Zealand, reported approximately 26,079,000 kg CO2e in total gross carbon emissions for 2024. This figure includes about 1,052,000 kg CO2e from Scope 1 emissions, 308,000 kg CO2e from Scope 2 emissions (location-based), and 24,719,000 kg CO2e from Scope 3 emissions.

In 2023, Comvita's total gross carbon emissions were approximately 34,944,000 kg CO2e. This comprised around 1,113,000 kg CO2e from Scope 1 emissions, 349,000 kg CO2e from Scope 2 emissions (location-based), and 33,482,000 kg CO2e from Scope 3 emissions.

For 2022, the company's total gross carbon emissions were approximately 32,004,000 kg CO2e, with about 1,022,000 kg CO2e from Scope 1 emissions, 429,000 kg CO2e from Scope 2 emissions (location-based), and 30,553,000 kg CO2e from Scope 3 emissions.

Comvita has set a near-term, science-aligned target, established in 2021, to reduce its New Zealand FY21 Scope 1 and 2 emissions by 50% by 2030. The company also aspires to be carbon neutral by FY25 for its Scope 1 and 2 emissions. Comvita is committed to net-zero emissions, as evidenced by its status with the Science Based Targets initiative (SBTi).